Project Details
| Status | Active |
|---|---|
| Effective start/end date | 4/24/22 → 4/23/32 |
A PHASE III, MULTICENTER, RANDOMIZED, OPEN LABEL STUDY OF ATEZOLIZUMAB (ANTI PD-L1 ANTIBODY) PLUS BEVACIZUMAB VERSUS ACTIVE SURVEILLANCE AS ADJUVANT THERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
- Abdelrahim, Maen (PI)
Project: Non Profit